Fluor (FLR) Q3 2025 earnings review
Adjusted Earnings Beat Masks Santos Charge and Stalled Growth Outlook
Fluor reported a strong quarter on the surface, with Adjusted EPS of $0.68 beating expectations and prompting a raise in full-year 2025 guidance. However, this was overshadowed by a massive $697 million GAAP net loss, driven by a $653 million pre-tax charge related to an adverse legal ruling on the long-completed Santos project. More concerning for the investment thesis is management's new outlook for FY2026, where they expect EBITDA to be only 'marginally better' than FY25, signaling a significant growth stall and pushing long-term targets out by at least a year. On the positive side, the company finalized its plan to monetize its NuScale investment and announced an aggressive $800 million share buyback program, providing a clear catalyst for shareholder returns.
🐂 Bull Case
The finalization of a plan to convert and sell its remaining 111 million NuScale shares by mid-2026 crystallizes a significant source of value and provides a clear path to returning capital to shareholders.
The company is targeting an additional $800 million in share repurchases through February 2026. This reflects confidence in cash flow and provides strong direct support for the stock.
The Urban Solutions segment remains a bright spot, with its backlog growing 8% YoY to $20.5 billion. It now constitutes 73% of the total company backlog and serves as the primary growth engine.
🐻 Bear Case
A $653 million charge on a 'long completed reimbursable project' is a severe blow, raising serious questions about the actual risk profile of the company's supposedly 'de-risked' 82% reimbursable backlog.
Management's forecast for FY26 EBITDA to be only 'marginally better' than FY25 represents a complete stall in growth and a 4-quarter delay to its long-term financial targets communicated earlier this year.
Total backlog of $28.2 billion is flat sequentially and down 10% YoY. The company is not winning work fast enough to replace revenue burn, which supports the weak forward-looking growth guidance.
⚖️ Verdict: 🔴
Bearish. While the NuScale monetization and buyback are significant positives, they are overshadowed by two fundamental negatives. The massive Santos charge on a 'reimbursable' project undermines the core 'de-risked' thesis, and the evaporation of the FY26 growth outlook represents a material negative change to the investment case. The adjusted EPS beat feels like a hollow victory against this backdrop.
Key Themes
$653M Santos Charge Questions 'Reimbursable' Risk Profile
The most significant event this quarter was the $653 million pre-tax charge in the Energy Solutions segment for a legal ruling on the Santos project in Australia. Management described the project as 'long completed' and 'reimbursable'. A charge of this magnitude on a project with this profile is a major red flag for risk management and contradicts the central narrative that the company's 82% reimbursable backlog is low-risk. This single event wiped out more than a year's worth of guided Adjusted EBITDA.
Growth Outlook Stalls; Long-Term Targets Delayed by a Year
Management signaled a dramatic slowdown in growth, stating that FY26 EBITDA is expected to be only 'marginally better' than FY25. This confirms that delays in new project awards, particularly in Energy Solutions, are having a severe impact. The CEO stated these deferrals are causing a 'roughly 4-quarter shift in EBIT delivery,' effectively pushing the company's multi-year growth targets out by a full year.
NuScale Monetization Plan Finalized, Fueling Buybacks
Fluor reached a comprehensive agreement to convert its remaining investment in NuScale into Class A shares, with a plan to fully monetize the stake by the end of Q2 2026. This is a major catalyst that unlocks significant value. Proceeds from initial share sales are already supporting an aggressive capital return program, with the company targeting an additional $800 million in share repurchases through February 2026.
Urban Solutions Remains the Sole Growth Engine
While the Energy segment struggles, Urban Solutions continues to perform well. Its backlog grew 8% YoY to $20.5 billion, making it the largest segment by far at 73% of the total company backlog. Strong performance is being driven by projects in mining (copper, rare earth), life sciences, and advanced technologies, providing a crucial offset to weakness elsewhere.
Energy Solutions Recovery Delayed
The Energy Solutions segment continues to face headwinds. Its backlog collapsed 42% YoY to $5.1 billion. Management cited 'trade and policy uncertainty, oversupply of chemicals and defunding of energy transition' as reasons for clients delaying final investment decisions. New awards in 2026 are now expected to be weighted towards the second half, indicating the recovery for this segment is still distant.
Client Hesitation on Large Capital Projects
Across the industry, clients are delaying Final Investment Decisions (FIDs) for large projects. For Fluor, this is most acute in the Energy sector but was also cited as a factor in the broader awards slowdown. This macro headwind is the primary driver of the delayed growth outlook and stagnant backlog.
Other KPIs
Stable sequentially but down 10% from $31.3 billion a year ago. The quality remains high with 82% of the backlog being reimbursable. However, the lack of growth is a primary concern, indicating that new awards are not keeping pace with project execution and revenue burn.
A strong performance that reverses the negative cash flow from the first half of the year (-$307M). This result prompted management to raise the full-year guidance to $250M-$300M (excluding the Santos payment), signaling effective working capital management on its major projects.
Up 21% YoY, with 99% being reimbursable. While a solid result, it follows a weak Q2 ($1.8B) and is insufficient to drive meaningful backlog growth. The company needs to consistently book over $4 billion per quarter to reverse the declining backlog trend.
Guidance
Accelerating. This is an upward revision from the prior range of $475M - $525M provided in Q2. The increase reflects strong Q3 performance and confidence in Q4 execution.
Reversing/Decelerating. This is a significant negative revision from prior long-term growth expectations. The midpoint of FY25 guidance is $525M; 'marginally better' implies almost no growth in FY26. This confirms that the company's growth trajectory has stalled for at least the next year.
Upward Revision. Guidance was increased from $200M - $250M, reflecting strong collections and working capital management in Q3. This guidance excludes the anticipated payment for the Santos ruling in Q4.